Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.

Oladunni FS, Park JG, Pino PA, Gonzalez O, Akhter A, Allué-Guardia A, Olmo-Fontánez A, Gautam S, Garcia-Vilanova A, Ye C, Chiem K, Headley C, Dwivedi V, Parodi LM, Alfson KJ, Staples HM, Schami A, Garcia JI, Whigham A, Platt RN, Gazi M, Martinez J, Chuba C, Earley S, Rodriguez OH, Mdaki SD, Kavelish KN, Escalona R, Hallam CRA, Christie C, Patterson JL, Anderson TJC, Carrion R, Dick EJ, Hall-Ursone S, Schlesinger LS, Alvarez X, Kaushal D, Giavedoni LD, Turner J, Martinez-Sobrido L, Torrelles JB. · 2020

Read Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. by Oladunni FS, Park JG, Pino PA, Gonzalez O, Akhter A, Allué-Guardia A, Olmo-Fontánez A, Gautam S, Garcia-Vilanova A, Ye C, Chiem K, Headley C, Dwivedi V, Parodi LM, Alfson KJ, Staples HM, Schami A, Garcia JI, Whigham A, Platt RN, Gazi M, Martinez J, Chuba C, Earley S, Rodriguez OH, Mdaki SD, Kavelish KN, Escalona R, Hallam CRA, Christie C, Patterson JL, Anderson TJC, Carrion R, Dick EJ, Hall-Ursone S, Schlesinger LS, Alvarez X, Kaushal D, Giavedoni LD, Turner J, Martinez-Sobrido L, Torrelles JB. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7705712.txt.

Introduction

Oladunni and co-authors test a mouse model for severe SARS-CoV-2 infection. The mice carry the human ACE2 gene under a skin-cell promoter. ACE2 is the door the virus uses to enter cells. A faithful small animal model is vital for testing vaccines and antivirals.

Infected mice died by day 6, with virus found in lung airways and brain. Their lungs and spleen showed a modest cytokine surge that peaked by day 2. A chemokine surge lasted longer and reached the brain. The authors say these mice are highly prone to the virus. They suit studies of how the disease unfolds and how well new drugs work.

Catalog record

CREATOROladunni FS, Park JG, Pino PA, Gonzalez O, Akhter A, Allué-Guardia A, Olmo-Fontánez A, Gautam S, Garcia-Vilanova A, Ye C, Chiem K, Headley C, Dwivedi V, Parodi LM, Alfson KJ, Staples HM, Schami A, Garcia JI, Whigham A, Platt RN, Gazi M, Martinez J, Chuba C, Earley S, Rodriguez OH, Mdaki SD, Kavelish KN, Escalona R, Hallam CRA, Christie C, Patterson JL, Anderson TJC, Carrion R, Dick EJ, Hall-Ursone S, Schlesinger LS, Alvarez X, Kaushal D, Giavedoni LD, Turner J, Martinez-Sobrido L, Torrelles JB.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE81 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7705712

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice By Fatai S. Oladunni, Jun-Gyu Park, Paula A. Pino, Olga Gonzalez, Anwari Akhter, Anna Allué-Guardia, Angélica Olmo-Fontánez, Shalini Gautam, Andreu Garcia-Vilanova, Chengjin Ye, Kevin Chiem, Colwyn Headley Published in: Nature Communications DOI: 10.1038/s41467-020-19891-7 ABSTRACT Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease would benefit from validated small animal models. Here, we show that transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) by the human cytokeratin 18 promoter (K18 hACE2) represent a susceptible rodent model. K18 hACE2 transgenic mice succumbed to SARS-CoV-2 infection by day 6, with virus detected in lung airway epithelium and brain. K18 ACE2 transgenic mice produced a modest TH1/2/17 cytokine storm in the lung and spleen that peaked by day 2, and an extended chemokine storm that was detected in both lungs and brain. This chemokine storm was also detected in the brain at day 6. K18 hACE2 transgenic mice are, therefore, highly susceptible to SARS-CoV-2 infection and represent a suitable animal model for the study of viral pathogenesis, and for identification and characterization of vaccines (prophylactic) and antivirals (therapeutics) for SARS-CoV-2 infection and associated severe COVID-19 disease. INTRODUCTION Human angiotensin-converting enzyme 2 (hACE2) protein is the functional receptor used by severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) to gain entry to cells1,2. Recently, hACE2 has also been described as the receptor for acute respiratory syndrome coronavirus 2 (SARS-CoV-2)3–5, the etiological agent responsible for coronavirus disease 2019 (COVID-19). SARS-CoV-2 emerged in the city of Wuhan, China, in December 2019, causing a pandemic that has dramatically impacted public health and socioeconomic activities across the world6–10. Importantly, hACE2 is widely expressed in the lung, central nervous system, cardiovascular system, kidneys, gut, and adipose tissues where it negatively regulates the renin-angiotensin system, and facilitates amino-acid transport5. K18 hACE2 transgenic mice [B6.Cg-Tg(K18-ACE2)2Prlmn/J] are susceptible to SARS-CoV-1 infection11 and recent reports suggest that K18 hACE2 transgenic mice can also be infected with SARS-CoV-212,13. hACE2 expression in K18 hACE2 transgenic mice is driven by the human cytokeratin 18 (K18) promoter11. Importantly, hACE2 expression in K18 hACE2 transgenic mice is observed in airway epithelial cells where SARS-CoV-1 and SARS-CoV-2 infections are typically initiated. Recent research indicates that hACE2-expressing mice are useful for studies related to SARS-CoV-2 pathogenesis and COVID-1912–16. A validated rodent model of SARS-CoV-2 infection could help to accelerate testing of vaccines (prophylactic) and antivirals (therapeutic) for the prevention and treatment, respectively, of SARS-CoV-2 infection and associated severe COVID-19 disease. Compared with large animals, a murine model would have desirable features of tractability, ease of use and availability, be cost efficient and permit mechanistic studies to identify attributes of severe COVID-19 outcomes in some but not all people who are infected. Transgenic mice expressing hACE2 have been developed using various promoters that produce mild-to-moderate SARS-CoV-2 infection in a variety of organs, in addition to physiological (weight loss, interstitial pneumonia) or immunological (anti-spike IgG) changes12–16. No transgenic mice models to date have led to SARS-CoV-2 infection-induced mortality15. Adenovirus-based delivery of hACE2 (Ad4-hACE2) to wild-type (WT) C57BL/6 mice resulted in susceptibility to SARS-CoV-2 infection but not mortality13,15. K18 hACE2 transgenic mice have previously been shown to represent a good animal model for SARS-CoV-1 infection and associated disease11. However, SARS-CoV-2 lethality in K18 hACE2 transgenic mice has not yet been fully determined. In this study, we infected K18 hACE2 transgenic mice with SARS-CoV-2 to assess the feasibility of its use as an animal model of SARS-CoV-2 infection and associated COVID-19 disease. Contrary to other constitutively or transiently expressing hACE2 mouse models12–19, K18 hACE2 transgenic mice were highly susceptible to SARS-CoV-2 infection, with all mice rapidly losing weight and succumbing to viral infection by 5–6 days post infection (DPI). Importantly, morbidity and mortality correlated with SARS-CoV-2 replication in the nasal turbinates, lungs, and brains at 2, 4, and 6 DPI. Notably, susceptibility was highly associated with a local and systemic chemokine storm, especially in the brain, and high levels of IFN-λ in the lungs by 6 DPI, with mild to moderate tissue pathology that included vasculitis, and the presence of SARS-CoV-2 nucleocapsid protein (NP) antigen and hACE2 expression in the nasal turbinates, lung epithelium and brain. In contrast, WT C57BL/6 mice survived viral infection with no changes in body weight and undetectable viral replication, NP antigen, and hACE2 expression. Altogether, our data provide evidence that K18 hACE2 transgenic mice represent an excellent animal model of SARS-CoV-2 infection and associated severe COVID-19 disease, providing the research community with a much-needed small animal model to evaluate vaccines and/or antivirals for SARS-CoV-2 infection and associated severe COVID-19 disease in vivo. RESULTS K18 hACE2 transgenic mice are susceptible to SARS-CoV-2 infection K18 hACE2 transgenic and WT C57BL/6 mice where i.n. mock-infected (PBS), or infected with 1 × 105 plaque forming units, (PFU) of SARS-CoV-2, USA-WA1/2020 strain, and followed for body weight loss and survival for 14 days. By 6 DPI, SARS-CoV-2-infected K18 hACE2 transgenic mice lost over 20% of their initial body weight, were lethargic with rough fur and hunched appearance, immobile, and did not eat or drink, and succumbed to the infection (Fig. 1a, b). All K18 hACE2 transgenic mice succumbed to infection by 6 DPI, with the exception of one that was humanely killed due to IACUC-defined endpoints. Mock-infected K18 hACE2 transgenic or WT C57BL/6 mice, or SARS-CoV-2-infected WT C57BL/6 mice appeared healthy, maintained weight, and all survived SARS-CoV-2 infection for the duration of this study (Fig. 1a, b). Differentiating by sex, we observed that SARS-CoV-2-infected male K18 hACE2 transgenic mice lost weight starting 1 DPI, at the rate of ~5% per day whereas SARS-CoV-2-infected female K18 hACE2 transgenic mice did not begin to lose weight until 3 DPI (Supplementary Fig 1). In both cases, after 3-DPI, morbidity indicators accelerated until all K18 hACE2 transgenic mice, independent of sex, succumbed to SARS-CoV-2 infection by 6 DPI (Supplementary Fig 1).Fig. 1Infection of K18 hACE2 transgenic and WT C57BL/6 mice with SARS-CoV-2.K18 hACE2 transgenic and WT C57BL/6 female and male mice were mock-infected or infected i.n. with 1 × 105 PFU of SARS-CoV-2. Body weight (a, n = 14 and n = 6 for K18 hACE2 transgenic mice infected and mock-infected respectively; n = 8 for WT infected and n = 6 for WT mock infected) and survival (b, n values equal as in a) were evaluated at the indicated DPI. Mice that loss >25% of their initial body weight were humanely euthanized. Error bars represent standard deviations (SD) of the mean for each group of mice. c–e K18 transgenic hACE2 (n = 34 mice distributed as n = 14 for 2 DPI, n = 14 for 4 DPI and n = 6 for 6 DPI, 50:50 male:female) and WT C57BL/6 (n = 16 mice distributed as n = 8 for 2 DPI and n = 8 for 4 DPI) mice were similarly infected and killed at 2 and 4 DPI and viral titers in different organs (nasal turbinate, trachea, lung, brain, heart, kidney, liver, spleen, small intestine, and large intestine) were determined by plaque assay (PFU/ml). Data from virus -containing organs and/or tissue samples are shown: nasal turbinates c, lungs d, and brain e. Symbols represent data from individual mouse, and bars represent the geometric means

Read the complete text